Biotech

All Articles

Editas profit Vertex Cas9 licensing legal rights for $57M

.Versus the scenery of a Cas9 license fight that rejects to pass away, Editas Medication is cashing ...

Ultragenyx tweaks gene treatment application to dial up efficiency

.A minority of patients taking Ultragenyx Drug's Wilson ailment genetics treatment UX701 have gone o...

Biopharma layoff price stabilizes in Q3: Strong Biotech review

.As summer months heat counts on cool down winds, hopes that this year would take wide-spread field ...

J &amp J goes down period 2 dengue prospect in latest switch from injections

.Johnson &amp Johnson's deprioritization of its infectious ailment pipe has actually claimed an addi...

Relay drops 10% of personnel after earlier discharges in July

.Accuracy medication biotech Relay Rehabs is shedding about 10% of its staff in efforts to simplify ...

Pentixapharm scores $22M IPO to accommodation radiopharma tests

.Pentixapharm has brought in virtually 20 thousand europeans ($ 22 million) from an IPO, with the Ge...

Lundbeck faucets Charles Waterway for AI-enabled neuro drug invention

.Lundbeck has tapped Charles Stream Laboratories' expert system functionalities to aid the finding o...

Big pharma, biotech 'won't automatically be cooperative' in AI: S&ampP

.Significant Pharma is investing greatly in AI to lower development timetables as well as foster tec...

I &amp I biotech Triveni raises $115M for preclinical antibodies

.Triveni Biography has actually roped in $115 million in series B funds to advance preclinical antit...

IGM pivots from cancer cells to autoimmune, shaking up C-suite

.IGM Biosciences ended in 2013 laying off staff and also improving its cancer cells pipeline. Now, t...